Total Payments
$8,264
2024 Payments
$410.17
Companies
23
Transactions
84
Medicare Patients
343
Medicare Billing
$56,516
Payment Breakdown by Category
Food & Beverage$4,305 (52.1%)
Consulting$3,150 (38.1%)
Travel$809.19 (9.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,305 | 78 | 52.1% |
| Consulting Fee | $3,150 | 1 | 38.1% |
| Travel and Lodging | $809.19 | 5 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,071 | 11 | $0 (2019) |
| Medtronic USA, Inc. | $1,754 | 17 | $0 (2019) |
| Focal Therapeutics, Inc. | $404.99 | 2 | $0 (2018) |
| West Therapeutics Development, LLC | $387.37 | 13 | $0 (2020) |
| BIOPROTECT MEDICAL, INC. | $221.20 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $200.83 | 2 | $0 (2024) |
| INSYS Therapeutics Inc | $154.05 | 10 | $0 (2018) |
| Varian Medical Systems, Inc. | $145.92 | 4 | $0 (2019) |
| GENZYME CORPORATION | $117.28 | 1 | $0 (2019) |
| Pfizer Inc. | $114.28 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $410.17 | 7 | BIOPROTECT MEDICAL, INC. ($221.20) |
| 2023 | $114.38 | 2 | Regeneron Healthcare Solutions, Inc. ($90.17) |
| 2022 | $24.75 | 1 | Myriad Genetic Laboratories, Inc. ($24.75) |
| 2021 | $48.34 | 1 | BOSTON SCIENTIFIC CORPORATION ($48.34) |
| 2020 | $190.52 | 5 | Pfizer Inc. ($114.28) |
| 2019 | $4,608 | 24 | AstraZeneca Pharmaceuticals LP ($3,821) |
| 2018 | $2,392 | 36 | Medtronic USA, Inc. ($1,185) |
| 2017 | $476.54 | 8 | Medtronic USA, Inc. ($270.56) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $48.87 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 10/17/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 09/30/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $43.72 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $110.66 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 10/02/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 09/01/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $90.17 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 06/28/2021 | BOSTON SCIENTIFIC CORPORATION | SPACEOAR VUE (Device) | Food and Beverage | In-kind items and services | $48.34 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/29/2020 | West Therapeutics Development, LLC | Subsys (Drug), Lazanda | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Opioid Agonist | ||||||
| 03/06/2020 | West Therapeutics Development, LLC | Subsys (Drug), Lazanda | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Opioid Agonist | ||||||
| 02/07/2020 | West Therapeutics Development, LLC | Subsys (Drug), Lazanda | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Opioid Agonist | ||||||
| 01/30/2020 | Pfizer Inc. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $114.28 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2020 | West Therapeutics Development, LLC | Subsys (Drug), Lazanda | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Opioid Agonist | ||||||
| 12/13/2019 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Diagnostic Imaging | ||||||
| 12/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $104.30 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2019 | West Therapeutics Development, LLC | Subsys (Drug), Lazanda | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Opioid Agonist | ||||||
| 11/12/2019 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Diagnostic Imaging | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $255.71 | General |
| Category: Oncology | ||||||
| 11/02/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $53.84 | General |
| Category: Oncology | ||||||
| 11/02/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $48.70 | General |
| Category: Oncology | ||||||
| 11/02/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $43.74 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 13 | 343 | 950 | $354,217 | $56,516 |
Total Patients
343
Total Services
950
Medicare Billing
$56,516
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatments | Facility | 2020 | 24 | 86 | $84,108 | $14,210 | 16.9% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2020 | 36 | 150 | $40,500 | $7,963 | 19.7% |
| 77263 | Management of radiation therapy, complex | Facility | 2020 | 36 | 37 | $32,190 | $5,410 | 16.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2020 | 23 | 294 | $44,100 | $4,896 | 11.1% |
| 77300 | Calculation of radiation therapy dose | Facility | 2020 | 31 | 134 | $19,832 | $3,818 | 19.2% |
| 77338 | Design and construction of device for radiation therapy | Facility | 2020 | 14 | 18 | $20,124 | $3,503 | 17.4% |
| 77470 | Special radiation treatment procedure | Facility | 2020 | 36 | 37 | $19,277 | $3,465 | 18.0% |
| 77295 | Management of radiation therapy, 3d | Facility | 2020 | 17 | 17 | $16,949 | $3,352 | 19.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 25 | 25 | $18,125 | $2,755 | 15.2% |
| 77290 | Management of radiation therapy, simulation, complex | Facility | 2020 | 26 | 30 | $12,780 | $2,164 | 16.9% |
| 77280 | Management of radiation therapy simulation, simple | Facility | 2020 | 16 | 58 | $17,980 | $1,868 | 10.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 48 | 52 | $21,112 | $1,706 | 8.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 12 | $7,140 | $1,405 | 19.7% |
About Dr. Robert Kwon, MD
Dr. Robert Kwon, MD is a Radiation Oncology healthcare provider based in Los Alamitos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841294337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Kwon, MD has received a total of $8,264 in payments from pharmaceutical and medical device companies, with $410.17 received in 2024. These payments were reported across 84 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,305).
As a Medicare-enrolled provider, Kwon has provided services to 343 Medicare beneficiaries, totaling 950 services with total Medicare billing of $56,516. Data is available for 1 year (2020–2020), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Los Alamitos, CA
- Active Since 06/13/2005
- Last Updated 01/31/2017
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1841294337
Products in Payments
- IMFINZI (Drug) $3,864
- KYPHON Balloon Kyphoplasty (Device) $849.06
- OSTEOCOOL RF ABLATION (Device) $782.97
- BioZorb (Device) $404.99
- Lazanda (Drug) $289.72
- BIOPROTECT BALLOON IMPLANT SYSTEM (Device) $221.20
- TAGRISSO (Drug) $207.07
- LIBTAYO (Biological) $200.83
- SYNDROS (Drug) $132.03
- INTELLIS (Device) $121.71
- LIBTAYO (Drug) $117.28
- XTANDI (Drug) $114.28
- Xofigo (Drug) $112.98
- Eclipse (Device) $107.13
- KEYTRUDA (Biological) $104.30
- Subsys (Drug) $97.65
- Axumin (Drug) $66.39
- SPACEOAR VUE (Device) $48.34
- PYLARIFY (Drug) $43.72
- Optune (Device) $42.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.